TecMed Acquires Ypsomed's Diabetes Care for CHF 420 Million

Deal News | Apr 22, 2025 | Legal Community Swiss

TecMed Acquires Ypsomed's Diabetes Care for CHF 420 Million

TecMed, a Burgdorf-based company controlled by Willy Michel, has agreed to acquire Ypsomed’s diabetes care business for CHF 420 million, a deal that includes an earn-out. TecMed specializes in intellectual property solutions for blood glucose measurement. The acquisition will integrate Ypsomed’s mylife Loop system into TecMed’s patch pump program. The closing of the transaction is expected in the latter half of 2025, with a new headquarters for 250 employees already under construction in Burgdorf. Kellerhals Carrard is advising TecMed, while Walder Wyss counsels the selling side throughout the transaction.

Sectors

  • Healthcare and Medical Devices
  • Legal Services

Geography

  • Switzerland – TecMed and Ypsomed are both based in Switzerland, and the transaction is significant to the Swiss healthcare and legal sectors.

Industry

  • Healthcare and Medical Devices – The acquisition involves companies providing solutions for diabetes care, which falls under the medical devices industry. TecMed focuses on blood glucose measurement solutions, aligning with the healthcare sector.
  • Legal Services – The article discusses the legal advisors involved in the transaction, highlighting the role of law firms Kellerhals Carrard and Walder Wyss in facilitating the deal.

Financials

  • CHF 420 million – The acquisition cost paid by TecMed for Ypsomed’s diabetes care business, which includes an earn-out.

Participants

NameRoleTypeDescription
TecMedBuyerCompanyBurgdorf-based company controlled by Willy Michel, focused on intellectual property solutions for blood glucose measurement.
YpsomedTargetCompanyA company that provides diabetes care products, including the mylife Loop system.
Kellerhals CarrardLegal Advisor for the BuyerCompanyLead counsel for TecMed in the acquisition deal.
Walder WyssLegal Advisor for the SellerCompanyLegal representative for Ypsomed throughout the transaction.
Willy MichelControllerPersonIndividual who controls TecMed.